LMAT (Health Care Equipment) Stock Valuation & Fair Value Significantly overvalued
LMAT (Health Care Equipment) trades at a blended P/E of 36.5, about 5% below its historical normal valuation, with a forward growth estimate of 9.6% and a PEG of 3.81. Analysts' one-year estimates have been hit 27% of the time.
Valuation flags
- High PEG (3.8x)
Frequently asked questions
Is LMAT overvalued?
At a blended P/E of 36.5 versus its historical normal P/E of 38.4, LMAT trades about 5% below its typical valuation, with a PEG of 3.81 on 9.6% forward growth. tickerseer currently rates it significantly overvalued.
What is LMAT's fair value and PEG?
LMAT trades at a blended P/E of 36.5 against a historical normal P/E of 38.4, a PEG of 3.81, and a forward growth estimate of 9.6%.
Has tickerseer's rating of LMAT changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.